Upload
sabina-passamonti
View
312
Download
1
Embed Size (px)
Citation preview
Transregional Network for Innovation and Technology Transfer to Improve Health CareRete transregionale per l’innovazione ed il trasferimento tecnologico per il miglioramento della sanitàTransregionalno omrežje za inovacijo in prenos tehnološkega znanja za izboljšanje zdravstva
Suggestions for: Exploitation of synergies, common actions and new project ideas for Danube RIS3 – priority HEALTH
Sabina Passamonti University of Trieste, Lead Partner Danube S3 Workshop: “Gathering opportunities
around RIS3 priorities” at Austrian Federal Ministry of Science, Research and
Economy, Freyung 3, 1014 Vienna 07.07.2015
What is the Danube S3 Workshop? See below or read more in http://s3platform.jrc.ec.europa.eu/s3-in-danube-vienna-2015
Thematic discussion group Health
“The workshop participants were divided in the smaller thematic discussion groups on ICT, health, energy and
sustainable innovation where 16 new project ideas were explored to start collaboration in S3 priorities.”
All other project ideas are available in: http://s3platform.jrc.ec.europa.eu/s3-in-danube-vienna-2015
Trans2Care project ideas and collaboration areas are presented here.
What future for Trans2Care?
• Replication? (we again …) • Imitation? (the others … here and elsewhere)
• Transposition? (the others … elsewhere)
• Evolution? (another thing…)
What future for Trans2Care? - some answers • Replication
– No, Trans2Care is not perfect; many pitfalls.
• Imitation – We do not recommend; pitfalls2 (no experience x
pitfalls imitation)
• Transposition – Careful: there are regional specificities
• Evolution – We recommend à amplification of opportunities
ACTIONS NEEDED
1. Refinement and development of the strategic core of Trans2Care • More solutions to closely link research with
innovation
2. More efficient and coordinated thematic research activities • More results that can be directly taken up
by hospitals, care services, SMEs, schools and public authorities
PRODUCTS tools, guidelines,
advices, networking, …
Trans2Care natural evolution in INTERREG Programmes
CORE STRATEGIC PROJECT developing solu-ons for linking biomedical research results with
innova-on
RESULTS Efficient R&I by thema5c projects
NeurodegeneraBve diseaeses
Cancer diseaeses
Cardiovascular diseaeses
Airways and pulmonary diseaeses
Metabolic diseaeses
SUPPORT FOR & IMITATION BY FOCUSSED, THEMATIC PROJECTS
BIG LP EFFORT
CAPITALISATION WITH Pacinno project (IPA-‐Adria-c 2007-‐2013) RegHealth-‐RI project
(Horizon 2020)
TARGET 3 Quality of
research-‐industry interplay
Currently under evalutation
TARGET 2 Quality of insBtuBons
TARGET 1 Quality of human
capital OUTPUTS TRAINING TOOLS
ACTION PLANS STRATEGY PAPERS
RESULTS
Biomedical researchers at ease both in the lab and
with entrepresises and public authoriBes. CreaBve
relaBonships
Our simple survey • Title: “Survey on joint applications to Interreg and
Horizon 2020 programmes-Health Topics” • 10 Questions • Sent to ca. 300 persons:
– Registered attendees of former Italy-Slovenia Cross-border Biomedical Conference (27.02.2014) (http://www.trans2care.eu/Sections.aspx?section=510.595)
– Professors and post-doc fellows of Dept. of Life Sciences – Trans2Care Partners
• Open 30.06.2015-06.07.2015 • 52 RESPONDENTS
The 10 questions of the survey 1. Can you list some key words describing your research expertise? 2. How would you describe your availability of research staff? 3. How would you describe the size of your grants? 4. What kind of funds do you usually get for your research? 5. What are your research objectives? 6. How severe is your shortage of funds? 7. Are you short of research staff? 8. Are you short of administration support? 9. How do you bypass the factors (funds, research and administrative
staff) that challenge your research? 10. What role do you prefer in a collaborative project?
19,61%&
15,69%&
11,76%&
37,25%&
19,61%&
0%& 5%& 10%& 15%& 20%& 25%& 30%& 35%& 40%&
I&have&no&staff,&I&work&alone&
I&have&only&pre=graduate&students&
I&have&only&PhD&student(s)&
I&have&a&non=permanent&research&team&(PhDs&and&post=docs)&
I&have&a&stable&research&team&
My#research#staff#
Funds and human capital baseline
30,00%%
44,00%%
16,00%%
14,00%%
0,00%%
0%% 5%% 10%% 15%% 20%% 25%% 30%% 35%% 40%% 45%% 50%%
None%
Small%grants%(ca.%20.000%€/year)%
Medium%grants%(ca.%80.000%€/year)%
Large%grants%(ca.160.000%€/year)%
I%have%no%needs%for%the%next%3%years%
My#usual#research#grants#
0,00%$
10,00%$
20,00%$
30,00%$
40,00%$
50,00%$
60,00%$
never$(0%)$
seldom$(<30%)$
o7en$(>70%)$
mixed$(30<50%)$
always$(100%)$
Percen
t'of'a
nswers'
The'kinds'of'my'grants'
public$compeDDve$
private$compeDDve$
contracts$with$public$bodies$
contracts$with$private$bodies$
8,51%&
12,77%&
31,91%&
40,43%&
4,26%&
0%& 10%& 20%& 30%& 40%&
absent&
I&have&mild&shortage,&but&no&research&ac@vi@es&disrup@on&
I&have&shortage,&but&I&compensate&with&collabora@ons&
I&have&severe&shortage,&so&I&must&limit&my&research&poten@al&
very&severe,&so&I&cannot&do&experimental&research&alone&or&in&collabora@on&
How$severe$is$your$shortage$of$funds?$
RESEARCH CHALLENGES
9,09%%
15,91%%
18,18%%
56,82%%
4,55%%
0%% 10%% 20%% 30%% 40%% 50%% 60%%
I%have%no%needs%(I%have%staff)–%
I%need%one%PhD%fellow–%
I%need%one%postAdoc%fellow–%
I%need%one%PhD%and%one%postAdoc%fellow–%
I%need%2%postAdoc%fellows–%
How$much$staff$do$you$need?$
14,58%'
41,67%'
8,33%'
18,75%'
10,42%'
0%' 10%' 20%' 30%' 40%' 50%'
No'shortage'
Mild'shortage'(I'compensate'by'doing'some'administraBve'work)''
Medium'shortage'(I'compensate'by'external'support)'
Severe'shortage'(I'must'limit'my'research'grant'applicaBon'potenBal)'
Very'severe'(I'cannot'be'Lead'Partner)'
Are$you$short$of$administra1ve$support?$
0,00%$
0,00%$
21,74%$
50,00%$
30,43%$
0%$ 10%$ 20%$ 30%$ 40%$ 50%$
never$
preferably$not$
rarely$
o7en$
always$
How$do$you$bypass$the$factors$(funds,$research$and$administra7ve$staff)$that$challenge$your$
research?$BY$COLLABORATIONS$
0%#
10%#
20%#
30%#
40%#
50%#
absolutely#no#
preferably#no#
neutral#
preferably#yes#
absolutely#yes#
0,00%# 2,22%#
28,89%#35,56%#
33,33%#
0,00%# 2,33%#11,63%#
48,84%#
37,21%#
Do#you#like#to#be#a#Project#Partner?#
In#a#small#project#(3@5#Partners)#
In#a#large#project#(8@12#Partners)#
0%#
10%#
20%#
30%#
40%#
50%#
absolutely#no#
preferably#no#
neutral#
preferably#yes#
absolutely#yes#
9,09%#
20,45%#
43,18%#
18,18%#
9,09%#
21,43%#
47,62%#
21,43%#
4,76%# 4,76%#
Do#you#like#to#be#the#Lead#partner?#
In#a#small#project#(3@5#Partners)#
In#a#large#project#(8@12#Partners)#
Considerations This could be steered by the Interreg Programme Authorities: • The projects calls could be clear in defining not
only WHAT is the ultimate goal of a given Programme but also HOW. – comprehensive strategic projects can support the the
thematic projects. – some strategic projects could be quite complementary
to some tasks of the Technical Secretariats – thematic projects (rather than the strategic ones) are
definitely more fitting than strategic ones to our biomedical research community.
Transregional Network for Innovation and Technology Transfer to Improve Health CareRete transregionale per l’innovazione ed il trasferimento tecnologico per il miglioramento della sanitàTransregionalno omrežje za inovacijo in prenos tehnološkega znanja za izboljšanje zdravstva
ProgeSo Rete Transregionale per l’innovazione ed il Trasferimento Tecnologico per il Miglioramento della Sanità finanziato nell’ambito del Programma per la Cooperazione Transfrontaliera Italia-‐Slovenia 2007-‐2013, dal Fondo europeo di sviluppo regionale e dai fondi nazionali. Projekt Transregionalno omrežje za inovacijo in prenos tehnološkega znanja za izboljšanje zdravstva sofinancirana v okviru Programa čezmejnega sodelovanja Slovenija-‐Italija 2007-‐2013 iz sredstev Evropskega sklada za regionalni razvoj in nacionalnih sredstev.
Thank you for your attention
Partners: LP – Università degli Studi di Trieste, PP1 – Kemijski InšBtut Ljubljana, PP1 – Kemijski InšBtut Ljubljana, PP2 – Scuola Internazionale Superiore di Studi AvanzaB, PP3 – Univerza v Novi Gorici, PP4 – Università di Ferrara, PP5 – Treviso Tecnologia, PP6 – Splošna Bolnišnica Dr. Franca Derganca, PP7 – Università Ca’ Foscari di Venezia, PP8 – Università di Udine, PP9 – IRCCS Burlo Garofalo, PP10 – Zavod Republike Slovenije Za Transfuzijsko Medicino, PP11 – Ortopedska Bolnišnica Valdoltra, PP12 – Univerza na Primorskem -‐ Fakulteta za Vede o Zdravju.
!
Sabina Passamonti, MD, PhD University of Trieste
[email protected] +393665898629